Teva letter to Sen. Warren and Rep. Jayapal

In a letter to Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.), Teva Pharmaceuticals defends its decision not to withdraw patents from the FDA's Orange Book. FTC and Congressional Democrats have pressured Teva and other pharma companies to voluntarily withdraw the patents, saying that they are improperly listed.